Multi-component Exercise on Mild Cognitive Impairment In Elderly Population
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03938051 |
|
Recruitment Status :
Completed
First Posted : May 6, 2019
Last Update Posted : September 6, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Mild Cognitive Impairment | Other: Experimental group Other: Control group | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 51 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Investigator) |
| Primary Purpose: | Treatment |
| Official Title: | Effects of Multicomponent Exercise on Mild Cognitive Impairment In Elderly Population ,a Randomized Control Trial |
| Actual Study Start Date : | January 15, 2019 |
| Actual Primary Completion Date : | June 30, 2019 |
| Actual Study Completion Date : | July 12, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Experimental group
Multi-component intervention
|
Other: Experimental group
Multicomponent intervention for twice weekly 55-60 minutes 6 weeks |
|
Experimental: Control group
treadmill walk
|
Other: Control group
20 minutes treadmill walk thrice weekly, 5-7 /10 subjective rate of perceived exertion |
- Mini mental state examination (MMSE) [ Time Frame: 6 week ]Changes from the Baseline, Mini mental state examination (MMSE): used to screen for cognitive impairment in elderly. It is as 30-point questionnaire. The reliability of the MMSE, ranging from 0.76 to 0.90.
- Trail making test (TMT) A & B [ Time Frame: 6 week ]Changes from the Baseline, Trail making test (TMT) A & B: It is a test of visual attention and task switching. It provides information about visual search speed, speed of processing and executive function. The test reliability for TMT (A -B) is 0.82 and 0.93. Time will be measured in seconds
- Montreal cognitive assessment (MoCA) [ Time Frame: 6 week ]Changes from the Baseline, Montreal cognitive assessment (MoCA): it is used widely for screening cognitive impairment.The test re-test reliability for MOCA is 0.966. Scoring. MoCA scores range between 0 and 30. A score of 26 or over is considered to be normal. In a study, normal people scored an average of 27.4; people with mild cognitive impairment (MCI) scored an average of 22.1; people with Alzheimer's disease scored an average of 16.2.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 55 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Both men and women
- Mini-Mental State Examination (MMSE) score 18- 23 (mild cognitive impairment)
Exclusion Criteria:
- Had current medical condition for which exercise is contraindicated
- Had neurodegenerative disease /stroke
- Oncologic patient with active treatment with chemotherapy
- Patient with arterial diseases in the past 12 months
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03938051
| Pakistan | |
| Riphah International University | |
| Islamabad, Federal, Pakistan, 44000 | |
| Principal Investigator: | Imran Amjad, PHD* | Riphah International University |
| Responsible Party: | Riphah International University |
| ClinicalTrials.gov Identifier: | NCT03938051 |
| Other Study ID Numbers: |
RiphahIU Hafsah Gul Khattak |
| First Posted: | May 6, 2019 Key Record Dates |
| Last Update Posted: | September 6, 2019 |
| Last Verified: | September 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Exercise Mild Cognitive Impairment Elderly Population |
|
Cognitive Dysfunction Cognition Disorders Neurocognitive Disorders Mental Disorders |

